SALT LAKE CITY, April 28, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the Ninth Annual JMP Securities Research Conference, at 12:30 p.m. Pacific on May 12, 2010, at the Ritz-Carlton Hotel in San Francisco, California.
